Yahoo
NasdaqCM - Delayed Quote USD

Obsidian Therapeutics, Inc. (OBX)

16.82 -0.27 (-1.58%)
At close: September 4 at 4:00:00 PM EDT
16.82 0.00 (0.00%)
After hours: September 4 at 7:30:02 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
Total Revenue
0
0
0
Operating Expense
99,344
105,667
91,255
Operating Income
-99,344
-105,667
-91,255
Net Non Operating Interest Income Expense
4,090
5,060
8,146
Pretax Income
-95,254
-100,607
-83,109
Tax Provision
0
0
0
Net Income Common Stockholders
-95,254
-100,607
-83,109
Diluted NI Available to Com Stockholders
-95,254
-100,607
-83,109
Basic EPS
-1.55
-1.63
-1.35
Diluted EPS
-1.55
-1.63
-1.35
Basic Average Shares
61,595.78
61,595.78
61,595.78
Diluted Average Shares
61,595.78
61,595.78
61,595.78
Total Operating Income as Reported
-99,344
-105,667
-91,255
Total Expenses
99,344
105,667
91,255
Net Income from Continuing & Discontinued Operation
-95,254
-100,607
-83,109
Normalized Income
-95,254
-100,607
-83,109
Interest Income
4,090
5,060
8,146
Net Interest Income
4,090
5,060
8,146
EBIT
-99,344
-105,667
-91,255
EBITDA
-97,898
-104,183
-89,728
Reconciled Depreciation
1,446
1,484
1,527
Net Income from Continuing Operation Net Minority Interest
-95,254
-100,607
-83,109
Normalized EBITDA
-97,898
-104,183
-89,728
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2024 - 7/27/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: